Percheron Therapeutics Limited (ASX:PER)
About Percheron Therapeutics Limited
Key Information
PER In the News
No news found.
ASX Announcements
Date | Announcement | File | Views |
---|---|---|---|
04/07/2024 | Notification regarding unquoted securities - PER | 19.02KB | 19K |
17/06/2024 | Deborah Ambrosini appointed as CFO & Company Secretary | 91.3KB | 10K |
03/06/2024 | Percheron appoints Dr Cathryn Clary as Chief Medical Advisor | 89.48KB | 35K |
31/05/2024 | Percheron to present at 2024 BIO International Convention | 1.64MB | 5.8K |
29/05/2024 | Price Sensitive PS Phase IIb study of ATL1102 in DMD completes recruitment | 109.16KB | 41K |
27/05/2024 | Preliminary Results of 9 Month Toxicology Study of ATL1102 | 99.9KB | 8.9K |
20/05/2024 | US Patent Granted for ATL1102 in Duchenne muscular dystrophy | 94.63KB | 2.7K |
06/05/2024 | WHO selects proposed INN for ATL1102 | 99.66KB | 6.1K |